|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| C07K 14/47 | |||
| A61K 39/00 |
| (11) | Number of the document | 1951281 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06826190.8 |
| Date of filing the European patent application | 2006-10-17 | |
| (97) | Date of publication of the European application | 2008-08-06 |
| (45) | Date of publication and mention of the grant of the patent | 2015-04-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/040719 |
| Date | 2006-10-17 |
| (87) | Number | WO 2007/047764 |
| Date | 2007-04-26 |
| (30) | Number | Date | Country code |
| 726608 P | 2005-10-17 | US | |
| 728304 P | 2005-10-20 | US |
| (72) |
SCHEINBERG, David, A., US
PINILLA-IBARZ, Javier, US
MAY, Rena, US
|
| (73) |
Sloan Kettering Institute For Cancer Research,
1275 York Avenue, New York, NY 10021,
US
|
| (54) | WT1 HLA CLASS II-BINDING PEPTIDES AND COMPOSITIONS AND METHODS COMPRISING SAME |
| WT1 HLA CLASS II-BINDING PEPTIDES AND COMPOSITIONS AND METHODS COMPRISING SAME |